Candida auris in healthcare settings
Due to its propensity to cause outbreaks and its antifungal resistance, C. auris poses a risk for patients in healthcare facilities in Europe. Difficulties with laboratory identification, combined with a lack of awareness of this new Candida species, might result in unnoticed outbreaks. There is a clear need to raise awareness in European healthcare facilities in order adapt laboratory testing strategies and implement enhanced control measures to prevent further hospital outbreaks.
Epidemiological update: Omicron variant of concern (VOC) – data as of 29 November 2021 (12:30)
29 Nov 2021 - As of 29 November 2021, 33 confirmed SARS-CoV-2 Omicron VOC cases have been reported by eight European Union and European Economic Area (EU/EEA) countries (Austria, Belgium, Czechia, Denmark, Germany, Italy, Netherlands, Portugal) according to information from public sources.
Surveillance of COVID-19 in long-term care facilities in the EU/EEA
29 Nov 2021 - Since the start of the COVID-19 pandemic, and as of November 2021, there have been over 800 000 fatal cases of COVID-19 (i.e. COVID-19-related/associated deaths) in the EU/EEA, with more than 88% in people aged over 65 years. By May 2020, deaths among LTCF residents accounted for 37–66% of all COVID-19-related deaths in EU/EEA countries, depending on the country (countries with available data)
ECDC publishes Threat assessment brief - Emergence of SARS-CoV-2 variant B.1.1.529
26 Nov 2021 - The European Centre for Disease Prevention and Control (ECDC) published a new Threat Assessment Brief on the new variant of concern (VOC) B.1.1.529, or Omicron. Based on currently available genetic information, the risks of this VOC are high, according to preliminary data.